Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
3096.7000 -11.30 (-0.36%)
NSE Nov 07, 2025 15:31 PM
Volume: 61,145
 

3096.70
-0.36%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Number of FII/FPI investors increased from 358 to 391 in Sep 2025 qtr.
More from Dr. Lal Pathlabs Ltd.
Recommended